Dishman Carbogen

DCAL29 Apr 2024

Pharmaceuticals

₹

+3.35 (+1.46%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Dishman Carbogen

Dishman Carbogen

Pharmaceuticals

DCAL29 Apr 2024

₹

+3.35 (+1.46%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
15-May-2019	D	Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015 we hereby inform that a Meeting of the Board of Directors of the Company was held today i.e. on Wednesday, the 15th day of May, 2019 which was commenced at 12:00 Noon and concluded at 02:20 P.M., in the said Board Meeting, among others, attached agenda were approved.	12-Sep-2019
09-Aug-2023	BC	With reference to the above, we hereby inform as per the details mentioned in the attached file.	01-Jun-2024
09-Aug-2023	BC	With reference to the above, we hereby inform as per the details mentioned in the attached file. Pls. find attached herewith Disclosure under Regulations 30 and 51 of SEBI(LODR) Regulations, 2015	01-Apr-2024
06-Feb-2024	BC	Dishman Carbogen Amcis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve the Un-Audited Financial Results of	14-Feb-2024
01-Nov-2023	BC	Dishman Carbogen Amcis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve Un-Audited Financial Results of the	08-Nov-2023
22-Aug-2023	BC	Pls. find attached herewith intimation regarding date of 16th Annual General Meeting. Please find enclosed herewith the copy of Notice of 16th Annual General Meeting ('AGM') of the Company schedul	27-Sep-2023

No Rights has been declared by DCAL

Book Closure

Record Date	Split Date	Purpose
01-Jun-2024	-	With reference to the above, we hereby inform as per the details mentioned in the attached file.
01-Apr-2024	-	With reference to the above, we hereby inform as per the details mentioned in the attached file. Pls. find attached herewith Disclosure under Regulations 30 and 51 of SEBI(LODR) Regulations, 2015
14-Feb-2024	-	Dishman Carbogen Amcis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve the Un-Audited Financial Results of
08-Nov-2023	-	Dishman Carbogen Amcis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve Un-Audited Financial Results of the
27-Sep-2023	-	Pls. find attached herewith intimation regarding date of 16th Annual General Meeting. Please find enclosed herewith the copy of Notice of 16th Annual General Meeting ('AGM') of the Company schedul

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Dishman Carbogen Amcis Ltd ₹233.00(+3.35/1.46%)	233.00	+3.35	3,600.52	59.04	0.00	0.88
Lupin Ltd ₹1,637.45(+21.50/1.33%)	1,637.45	+21.50	73,646.94	128.34	35.73	3.82
Ipca Laboratories Ltd ₹1,334.00(-4.50/-0.34%)	1,334.00	-4.50	33,958.31	90.83	61.69	5.47
J B Chemicals & Pharmaceuticals Ltd ₹1,906.65(+41.60/2.23%)	1,906.65	+41.60	28,944.61	77.48	57.14	10.78
Sanofi India Ltd ₹8,277.50(+3.35/0.04%)	8,277.50	+3.35	19,055.37	38.57	32.28	18.77
IOL Chemicals & Pharmaceuticals Ltd ₹396.50(-3.00/-0.75%)	396.50	-3.00	2,345.28	-2.77	13.60	1.48

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	86.82	59.72	69.55	113.13	78.40	106.54
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	86.82	59.72	69.55	113.13	78.40	106.54
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	13.11	38.71	14.44	14.79	12.36	20.88
Total Income	99.93	98.43	83.99	127.92	90.76	127.42
Total Expenditure	83.65	65.69	74.57	106.78	83.60	105.39
PBIDT	16.28	32.74	9.42	21.14	7.16	22.03
Interest	17.14	17.42	17.76	17.03	14.66	13.62
PBDT	-0.86	15.32	-8.34	4.11	-7.50	8.41
Depreciation	26.22	24.58	24.69	23.45	2.89	35.20
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-8.90	-3.48	-11.70	-9.11	-3.85	-9.51
Reported Profit After Tax	-18.18	-5.78	-21.33	-10.23	-6.54	-17.28
Extra-ordinary Items	0.00	-3.05	0.00	0.00	-2.00	0.00
Adjusted Profit After Extra-ordinary item	-18.18	-2.73	-21.33	-10.23	-4.54	-17.28

EPS (Unit Curr.)	-1.16	-0.37	-1.36	-0.65	-0.42	-1.10
EPS (Adj) (Unit Curr.)	-1.16	-0.37	-1.36	-0.65	-0.42	-1.10
Calculated EPS (Unit Curr.)	-1.16	-0.37	-1.36	-0.65	-0.42	-1.10
Calculated EPS (Adj) (Unit Curr.)	-1.16	-0.37	-1.36	-0.65	-0.42	-1.10
Calculated EPS (Ann.) (Unit Curr.)	-4.64	-1.47	-5.44	-2.61	-1.67	-4.41
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-4.64	-1.47	-5.44	-2.61	-1.67	-4.41
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	31.36	31.36	31.36	31.36	31.36	31.36
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	2.00	2.00	2.00	2.00	2.00	2.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	18.75	54.82	13.54	18.69	9.13	20.68
PBDTM(%)	-0.99	25.65	-11.99	3.63	-9.57	7.89
PATM(%)	-20.94	-9.68	-30.67	-9.04	-8.34	-16.22

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	651.09	586.59	723.38	618.56	639.79	613.96
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	651.09	586.59	723.38	618.56	639.79	613.96
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	6.05	8.47	6.53	6.75	6.50	8.85
Total Income	657.14	595.06	729.91	625.31	646.29	622.81
Total Expenditure	609.98	528.79	601.52	612.74	528.45	535.36
PBIDT	47.16	66.27	128.39	12.57	117.84	87.45
Interest	33.08	27.49	28.45	24.43	21.91	20.17
PBDT	14.08	38.78	99.94	-11.86	95.93	67.28
Depreciation	80.37	75.04	70.45	75.74	50.33	79.57
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.80	7.35	19.72	-2.03	10.36	8.58
Deferred Tax	-7.46	-2.71	-7.23	-14.85	-11.72	-10.82
Reported Profit After Tax	-59.63	-40.90	17.00	-70.72	46.96	-10.05
Minority Interest After NP	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit after Minority Interest	-59.63	-40.90	17.00	-70.72	46.96	-10.05

Extra-ordinary Items	0.00	-2.43	0.00	-45.62	-1.96	0.00
Adjusted Profit After Extra-ordinary item	-59.63	-38.47	17.00	-25.10	48.92	-10.05

EPS (Unit Curr.)	-3.80	-2.61	1.08	-4.51	3.00	-0.64
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	31.36	31.36	31.36	31.36	31.36	31.36

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	7.24	11.30	17.75	2.03	18.42	14.24
PBDTM(%)	2.16	6.61	13.82	-1.92	14.99	10.96
PATM(%)	-9.16	-6.97	2.35	-11.43	7.34	-1.64

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	31.36	31.36	31.36	31.38	32.28	32.28
Reserves Total	4082.95	4200.42	4643.26	4764.47	4860.09	4759.30
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	4114.31	4231.78	4674.62	4795.85	4892.37	4791.58
Secured Loans	589.85	526.96	526.27	391.28	531.02	605.51
Unsecured Loans	3.55	7.86	11.74	181.41	53.34	16.06
Total Debt	593.40	534.82	538.01	572.69	584.36	621.57
Total Liabilities	4707.71	4766.60	5212.63	5368.54	5476.73	5413.15
APPLICATION OF FUNDS :
Gross Block	2456.62	2338.77	2364.28	2344.43	2293.17	2293.18
Less : Accumulated Depreciation	1074.32	982.79	854.63	711.90	577.85	440.35
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	1382.30	1355.98	1509.65	1632.53	1715.32	1852.83
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	142.89	117.77	121.20	88.85	69.78	47.89
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	2912.85	3032.28	2881.71	2900.11	2906.69	2937.10
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	182.66	196.90	184.40	213.64	222.61	169.09
Sundry Debtors	146.80	65.66	118.89	144.90	130.15	140.02
Cash and Bank	68.43	86.47	80.32	65.13	47.35	21.29
Loans and Advances	176.23	195.57	272.61	284.01	316.45	328.69
Total Current Assets	574.12	544.60	656.22	707.68	716.56	659.09
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	208.85	152.44	143.11	195.37	140.08	176.84
Provisions	1.92	1.90	2.04	2.03	4.22	1.84
Total Current Liabilities	210.77	154.34	145.15	197.40	144.30	178.68
Net Current Assets	363.35	390.26	511.07	510.28	572.26	480.41
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	193.06	197.43	46.68	31.57
Deferred Tax Liability	60.15	114.41	379.77	338.25	179.29	153.85
Net Deferred Tax	-60.15	-114.41	-186.71	-140.82	-132.61	-122.28
Total Assets	4741.24	4781.88	4836.92	4990.95	5131.44	5195.95
Contingent Liabilities	606.84	610.14	389.92	460.30	443.13	452.74

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	31.36	31.36	31.36	31.38	32.28	32.28
Reserves Total	5778.31	5517.58	5667.46	5683.68	5346.81	5075.05
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	5809.67	5548.94	5698.82	5715.06	5379.09	5107.33
Minority Interest	0.00	0.00	0.00	0.00	0.00	0.00
Secured Loans	1824.51	1420.79	1165.89	915.51	969.62	921.92
Unsecured Loans	384.34	409.10	422.96	441.93	72.55	172.91
Total Debt	2208.85	1829.89	1588.85	1357.44	1042.17	1094.83
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	400.17	430.00	316.13	294.08	248.31	234.34
Total Liabilities	8418.69	7808.83	7603.80	7366.58	6669.57	6436.50
APPLICATION OF FUNDS :
Gross Block	9463.42	8638.80	8160.78	7895.78	6903.85	6627.93
Less: Accumulated Depreciation	3275.69	2866.10	2462.50	2217.86	1806.28	1562.06
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	6187.73	5772.70	5698.28	5677.92	5097.57	5065.87
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	1043.25	779.51	485.78	234.17	175.25	150.71
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	249.07	324.36	172.22	190.63	167.13	195.78
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	803.80	645.12	515.65	580.87	548.62	484.56
Sundry Debtors	589.91	473.42	420.71	577.43	445.30	444.40
Cash and Bank	189.17	172.09	307.74	160.98	95.67	69.06
Loans and Advances	158.51	255.56	343.60	353.08	444.26	453.78
Total Current Assets	1741.39	1546.19	1587.70	1672.36	1533.85	1451.80
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	903.63	668.69	550.61	670.40	465.25	525.26
Provisions	56.26	31.37	19.92	18.37	53.29	82.61
Total Current Liabilities	959.89	700.06	570.53	688.77	518.54	607.87
Net Current Assets	781.50	846.13	1017.17	983.59	1015.31	843.93
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	14.24	30.05	236.53	236.38	236.02	222.03
Deferred Tax Liability	75.15	155.36	418.06	374.44	368.42	346.67
Net Deferred Tax	-60.91	-125.31	-181.53	-138.06	-132.40	-124.64
Other Assets	218.05	211.44	411.88	418.33	346.71	304.85
Total Assets
Contingent Liabilities	442.92	415.10	394.43	403.64	354.96	241.10

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	24.88	16.36	26.33	28.00	17.77
Net Cash from Operating Activities	-52.90	227.35	-1.51	196.70	119.72
Net Cash Used In Investing Activities	40.71	-172.67	62.07	-74.30	-24.17
Net Cash Used In Financing Activities	1.38	-46.16	-70.53	-124.07	-85.32
Net Inc./Dec In Cash And Cash Equivalents	-10.81	8.52	-9.97	-1.67	10.23
Cash And Cash Equivalents At End Of The Year	14.07	24.88	16.36	26.33	28.00

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

59.32%

FII Shareholding

8.70%

DII Shareholding

2.37%

Public Shareholding

29.61%

**Promoter pledged shareholding 59.32%

About Dishman Carbogen Amcis Ltd

Dishman Carbogen Amcis Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 3597.39 crores. It has reported a sales of Rs. 86.82 crores and a net profit of Rs. -18.18 crores for the quarter ended December 2018. The company management includes Janmejay R Vyas, Janmejay R Vyas,Deohooti J Vyas,Arpit J Vyas,Sanjay S Majmudar,Ashok C Gandhi,Subir Kumar Das,Rajendra S Shah,Shrima Dave,Maitri K Mehta (Dishman Carbogen Amcis Ltd) among others.

Chairman

Janmejay R Vyas

Registered office

Dishman Corporate House,Iscon-Bopal Road Ambli,Ahmedabad,Gujarat,380058

FAX :

Background

Incorporation Year2007

Face Value₹2

Market Lot1

How to buy Dishman Carbogen shares on nse?

To buy Dishman Carbogen shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Dishman Carbogen share price today?

The Dishman Carbogen shares price on nse is Rs.233 today.

What is the market cap of Dishman Carbogen shares on NSE ?

The company has a market capitalization of Rs.3600.52Cr

What is the PE & PB ratio of Dishman Carbogen shares ?

PE is 0 and PB is 0.88

What is the 52 Week High and Low of Dishman Carbogen shares?

Dishman Carbogen stock price high: Rs.283 Dishman Carbogen stock price low: Rs.113.1